Search Within

David G Pfister

  1. "Biostatistics Service"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (31)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (68)
  2. Department of Medicine (68)
  3. Epidemiology and Biostatistics (68)
  4. Head and Neck Service (68)
  5. Solid Tumor Oncology Division (68)
  6. Surgery (37)

More Groups

People
  1. Eric Sherman (49)
  2. Nancy Lee (34)
  3. Alan Ho (28)
  4. Sofia Haque (24)
  5. Zhigang Zhang (23)
  6. Lara Dunn (22)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (5)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. International Journal of Radiation Oncology, Biology, Physics (15)
  3. Annals of Oncology (4)
  4. Cancer (4)
  5. JCO Oncology Practice (3)
  6. International Journal of Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Elsevier Inc. (16)
  3. Oxford University Press (6)
  4. Wiley Blackwell (5)
  5. John Wiley & Sons (2)
  6. Nature Publishing Group (2)

More Publishers

Results (68)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma
    Journal Article

    McBride, S.; Sherman, E.; Tsai, C. J.; Baxi, S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D.; Michel, L. S.; Young, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Split high-dose cisplatin: An alternate high-dose cisplatin administration schedule for definitive chemoradiation in oropharyngeal cancer
    Meeting Abstract

    Kang, J. J.; Tchekmedyian, V.; Fan, M.; Wang, H.; Kitpanit, S.; Mohamed, N.; Rybkin, A.; Lee, A.; Chen, L.; Yu, Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer
    Journal Article

    Beckham, T. H.; Barney, C.; Healy, E.; Wolfe, A. R.; Branstetter, A.; Yaney, A.; Riaz, N.; McBride, S. M.; Tsai, C. J.; Kang, J.; more...
    International Journal of Cancer (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx
    Meeting Abstract

    Tchekmedyian, V.; Ho, A. L.; Dunn, L.; Fetten, J. V.; Pfister, D. G.; Lobaugh, S.; Zhang, Z.; Kang, J.; Chen, L.; Riaz, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma
    Journal Article

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Baxi, S.; Katabi, N.; Antonescu, C. R.; Ostrovnaya, I.; Haque, S. S.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save